Article Information
History
- September 27, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Oliver Bürzle1,
- Dominik Menges1,
- Julian D. Maier1,
- Daniel Schams1,
- Milo Puhan1,
- Jan Fehr1,†,
- Tala Ballouz1,* and
- Anja Frei1,*,#
- 1Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich (UZH), Zurich, Switzerland
- ↵#Corresponding Author
Anja Frei, PhD, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001 Zurich, Switzerland, E-Mail: anja.frei{at}uzh.ch | Phone: +41 44 634 43 60 - ↵†Alternate Corresponding Author
Jan Fehr, MD, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Hirschengraben 84, 8001 Zurich, Switzerland, E-Mail: jan.fehr{at}uzh.ch | Phone: +41 44 634 46 79
↵* Shared last authorship due to equal contribution.
Posted September 27, 2022.
Comparative adverse effects, perceptions and attitudes related to BNT162b2, mRNA1273, or JNJ-78436735 SARS-CoV-2 vaccines: A population-based longitudinal cohort
